PET/CT is a cost-effective tool against cancer: synergy supersedes singularity

Detalles Bibliográficos
Autores principales: Fischer, Barbara Malene, Siegel, Barry A., Weber, Wolfgang A., von Bremen, Konrade, Beyer, Thomas, Kalemis, Antonis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969342/
https://www.ncbi.nlm.nih.gov/pubmed/27178271
http://dx.doi.org/10.1007/s00259-016-3414-5
_version_ 1782445768069611520
author Fischer, Barbara Malene
Siegel, Barry A.
Weber, Wolfgang A.
von Bremen, Konrade
Beyer, Thomas
Kalemis, Antonis
author_facet Fischer, Barbara Malene
Siegel, Barry A.
Weber, Wolfgang A.
von Bremen, Konrade
Beyer, Thomas
Kalemis, Antonis
author_sort Fischer, Barbara Malene
collection PubMed
description
format Online
Article
Text
id pubmed-4969342
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-49693422016-08-17 PET/CT is a cost-effective tool against cancer: synergy supersedes singularity Fischer, Barbara Malene Siegel, Barry A. Weber, Wolfgang A. von Bremen, Konrade Beyer, Thomas Kalemis, Antonis Eur J Nucl Med Mol Imaging Editorial Springer Berlin Heidelberg 2016-05-13 2016 /pmc/articles/PMC4969342/ /pubmed/27178271 http://dx.doi.org/10.1007/s00259-016-3414-5 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Editorial
Fischer, Barbara Malene
Siegel, Barry A.
Weber, Wolfgang A.
von Bremen, Konrade
Beyer, Thomas
Kalemis, Antonis
PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title_full PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title_fullStr PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title_full_unstemmed PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title_short PET/CT is a cost-effective tool against cancer: synergy supersedes singularity
title_sort pet/ct is a cost-effective tool against cancer: synergy supersedes singularity
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969342/
https://www.ncbi.nlm.nih.gov/pubmed/27178271
http://dx.doi.org/10.1007/s00259-016-3414-5
work_keys_str_mv AT fischerbarbaramalene petctisacosteffectivetoolagainstcancersynergysupersedessingularity
AT siegelbarrya petctisacosteffectivetoolagainstcancersynergysupersedessingularity
AT weberwolfganga petctisacosteffectivetoolagainstcancersynergysupersedessingularity
AT vonbremenkonrade petctisacosteffectivetoolagainstcancersynergysupersedessingularity
AT beyerthomas petctisacosteffectivetoolagainstcancersynergysupersedessingularity
AT kalemisantonis petctisacosteffectivetoolagainstcancersynergysupersedessingularity

Ejemplares similares